Skip to main content
EnglishEN
European Commission logo print header

Training next level scientists and researchers to develop highly selective and safe insecticides

Project description

DEENESFRITPL

Towards the development of low-risk insecticides

Insecticides are substances that help eliminate insects and mites that cause human diseases such as malaria. While there are benefits to their use, they can also pose a serious threat to both wildlife and humans, for example through toxic residues in food and water. This issue has encouraged research into the creation of low-risk insecticides. One area research has explored is the role of the enzyme cytochrome P450 (CYP) in the sensitivity to insecticides. The EU-funded CypTox project will exploit the CYP metabolic/detoxification pathway of target and non-target organisms in order to develop insecticides that are highly selective and safe. The project’s work will also lead to state-of-the-art biotechnology platforms.

Objective

Some of the most acute challenges that the world faces are caused by insects and mites that seriously threaten human health and food security. Their control is primarily achieved by the use of insecticides: e.g. malaria prevalence has halved since 2000, saving 660 million lives, with 80% of the reduction being attributable to the use of insecticides. However, both limited availability of low risk insecticides (“insecticides that only fight the bad bugs’) and insecticide resistance represent major threats. So, there is an urgent need to develop novel, safe insecticides. Earlier research pointed to a discriminatory role for the enzyme cytochrome P450 (CYP) in the sensitivity to insecticides. CypTox will exploit the CYP metabolic/detoxification pathway of target and non-target organisms, to develop insecticides, efficient against selected insect & mite major pests and vectors, but highly selective and safe for mammals, pollinators and the environment. Outcomes will also include significantly beyond the state of the art biotechnology platforms (high-throughput cell/enzyme- screening assays and in silico pipelines), that will advance research capabilities for future developments of low risk insecticides. CypTox will provide excellent research training within a creative and flexible environment that actively promotes the integration of academic rigor and commercial pragmatism through mobility between sectors and focused training events. The size and balance of a highly motivated consortium (6 AC/6 industrial–of which 3 SME & 3 TC; 300 well distributed secondments), the involvement of experienced PIs in Horizon2020 and ERC projects and the modern communication, dissemination and exploitation approaches will ensure efficient implementation and impact, at several levels. Enhanced career perspectives for scientists and researchers will be achieved by building a sustainable multidisciplinary and inter-sectoral network, integrating world leading researchers and stakeholders.

Fields of science

Keywords

Programme(s)

Topic(s)

Call for proposal

H2020-MSCA-RISE-2020

See other projects for this call

Funding Scheme

MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

Coordinator

IDRYMA TECHNOLOGIAS KAI EREVNAS
Net EU contribution
€ 464 600,00
Address
N PLASTIRA STR 100
70013 Irakleio
Greece

See on map
Region
Νησιά Αιγαίου Κρήτη Ηράκλειο
Activity type
Research Organisations
Links
Total cost
€ 464 600,00

Participants (14)

Partners (3)

Share this page

Download

Last update: 22 April 2024

My Booklet

Permalink: https://cordis.europa.eu/project/id/101007917

European Union, 2024